hydrochlorothiazide and labetalol

hydrochlorothiazide has been researched along with labetalol in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-199015 (37.50)18.7374
1990's6 (15.00)18.2507
2000's8 (20.00)29.6817
2010's10 (25.00)24.3611
2020's1 (2.50)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Faller, B; Wohnsland, F1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Akamatsu, M1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Apstein, CS; Battinelli, NJ; Bernard, SA; Foster, E; Huntington-Coats, M; Plehn, JF1
Fraser, I; Howes, L; Kincaid-Smith, PS; Louis, W; MacDonald, G; Matthews, PG; McGrath, BP; Rallings, M; Scheinkestel, C; Whitworth, JA1
Due, D; Forbes, WP; Jenkins, P; Lucas, C; Mendels, J; Sirgo, MA1
Due, DL; Sirgo, MA; Toth, PD; Vidt, DG; Weidler, DJ1
Ahmad, S; Glasser, SP; Lucas, C; Lutz, LJ; Materson, BJ; Morledge, JH; Ramanathan, KB; Saunders, E; Schnaper, HW; Vlachakis, ND1
Curry, C; Hinds, J; Kong, BW; Medakovic, M; Poland, M; Roper, K; Saunders, E1
Bleicher, JM; Nugent, CA; Plachetka, JR1
Blasucci, DJ; Falliers, CJ; Maloy, JW; Medakovic, M; Vrchota, J1
Burford, JG; Conrad, SA; George, RB; Hudson, L; Light, RW; Manocha, KL1
Kalbfleisch, JH; Kochar, MS; Tyson, J1
Burford, JG; Chetty, K; Conrad, SA; George, RB; Hudson, LD; Light, RW; Manocha, K1
Carr, AA; Flamenbaum, W; Materson, BJ; McMahon, FG; Poland, M; Weber, MA1
Bengtsson, C1
Burford, JG; Conrad, SA; George, RB; Kinasewitz, GT; Manocha, K1
Chetty, KG; Light, RW; Stansbury, DW1
Frishman, WH; Johnson, BF; Michelson, EL; Poland, MP1
Bloomfield, SS; Gantt, CL; Lucas, CP; Medakovic, M; Poland, MP1
Dal Palu, C; Hlede, M; Morandin, F; Palatini, P; Pessina, AC; Rossi, GP; Semplicini, A; Sperti, G1
de Vries, TW; Heijmans, HS; van der Veer, E1
Allen, LV; Erickson, MA1
Harkins, KG; Long, RC; Minor, DS; Wofford, MR1
Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A1
Aboul-Enein, HY; Ali, I; ALOthman, ZA; Alsheetan, KM1

Reviews

1 review(s) available for hydrochlorothiazide and labetalol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

14 trial(s) available for hydrochlorothiazide and labetalol

ArticleYear
Double-blind study of dilevalol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:5

    Topics: Adult; Aged; Blood Pressure; Body Weight; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Middle Aged

1990
The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
    Journal of the National Medical Association, 1991, Volume: 83, Issue:10

    Topics: Black People; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Lipids; Lipoproteins; Male; Middle Aged; Prospective Studies

1991
Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring.
    Journal of clinical pharmacology, 1990, Volume: 30, Issue:6

    Topics: Aged; Blood Pressure; Blood Pressure Determination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Monitoring, Physiologic; Random Allocation; Risk Factors; Time Factors

1990
Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
    The American journal of cardiology, 1989, Jun-05, Volume: 63, Issue:19

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Cholesterol; Coronary Disease; Double-Blind Method; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Lipoproteins; Male; Metoprolol; Middle Aged; Multicenter Studies as Topic; Random Allocation; Risk Factors; Supination; Triglycerides

1989
Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aging; Analysis of Variance; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Middle Aged; Posture; Random Allocation

1985
Labetalol compared with propranolol in the treatment of black hypertensive patients.
    Journal of clinical hypertension, 1987, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Aged; Black People; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Lipids; Male; Middle Aged; Propranolol; Prospective Studies; Random Allocation

1987
The effects of treatments with labetalol and hydrochlorothiazide on ventilatory function of asthmatic hypertensive patients with demonstrated bronchosensitivity to propranolol.
    Journal of clinical hypertension, 1985, Volume: 1, Issue:1

    Topics: Adolescent; Adult; Aged; Asthma; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Middle Aged; Respiration

1985
Concomitant therapy with labetalol and hydrochlorothiazide in moderate to moderately severe essential hypertension.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:6

    Topics: Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Random Allocation

1985
Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with asthma and propranolol sensitivity.
    Chest, 1985, Volume: 88, Issue:6

    Topics: Adolescent; Adult; Aged; Asthma; Clinical Trials as Topic; Drug Evaluation; Female; Forced Expiratory Volume; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Respiration

1985
Monotherapy with labetalol compared with propranolol. Differential effects by race.
    Journal of clinical hypertension, 1985, Volume: 1, Issue:1

    Topics: Adult; Aged; Black or African American; Bradycardia; Clinical Trials as Topic; Dizziness; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Humans; Hydrochlorothiazide; Labetalol; Male; Middle Aged; Propranolol; Sexual Dysfunction, Physiological; White People

1985
Effects of labetalol in hypertensive patients with chronic obstructive pulmonary disease.
    Chest, 1983, Volume: 83, Issue:3

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Exercise Test; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Lung Diseases, Obstructive; Male; Middle Aged; Random Allocation; Spirometry

1983
Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with mild chronic obstructive pulmonary disease.
    The American journal of medicine, 1983, Oct-17, Volume: 75, Issue:4A

    Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Forced Expiratory Volume; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Lung Diseases, Obstructive; Middle Aged; Respiration; Vital Capacity

1983
Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    The American journal of medicine, 1983, Oct-17, Volume: 75, Issue:4A

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Lipids; Male; Metoprolol; Middle Aged

1983
Step II treatment with labetalol for essential hypertension.
    The American journal of medicine, 1983, Oct-17, Volume: 75, Issue:4A

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Middle Aged

1983

Other Studies

25 other study(ies) available for hydrochlorothiazide and labetalol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
    Journal of medicinal chemistry, 2001, Mar-15, Volume: 44, Issue:6

    Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water

2001
Cheminformatic models to predict binding affinities to human serum albumin.
    Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids

2001
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Bioorganic & medicinal chemistry, 2007, Jun-01, Volume: 15, Issue:11

    Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship

2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
    Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19

    Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Importance of physicochemical properties for the design of new pesticides.
    Journal of agricultural and food chemistry, 2011, Apr-13, Volume: 59, Issue:7

    Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic

2011
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Regression of left ventricular hypertrophy in "previously untreated" hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy.
    Cardiovascular drugs and therapy, 1992, Volume: 6, Issue:2

    Topics: Adult; Aged; Black People; Blood Pressure; Cardiomegaly; Drug Therapy, Combination; Echocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Middle Aged

1992
Labetalol in the treatment of elderly patients with mild essential hypertension.
    The Journal of the American Osteopathic Association, 1988, Volume: 88, Issue:3

    Topics: Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Male; Random Allocation

1988
The use of labetalol for the treatment of hypertension in patients with reversible airway obstruction.
    Journal of clinical hypertension, 1985, Volume: 1, Issue:1

    Topics: Airway Resistance; Asthma; Bronchitis; Forced Expiratory Flow Rates; Forced Expiratory Volume; Humans; Hydrochlorothiazide; Hypertension; Labetalol

1985
Impairment of physical performance after treatment with beta blockers and alpha blockers.
    British medical journal (Clinical research ed.), 1984, Mar-03, Volume: 288, Issue:6418

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Alprenolol; Heart Rate; Humans; Hydrochlorothiazide; Labetalol; Male; Metoprolol; Physical Exertion; Pindolol; Prazosin; Propranolol; Running

1984
Intravenous labetalol in severe hypertension.
    British journal of clinical pharmacology, 1982, Volume: 13, Issue:1 Suppl

    Topics: Administration, Oral; Amiloride; Ethanolamines; Hydrochlorothiazide; Hypertension; Infusions, Parenteral; Injections, Intravenous; Labetalol; Time Factors

1982
Warfarin embryopathy: patient, possibility, pathogenesis and prognosis.
    British journal of obstetrics and gynaecology, 1993, Volume: 100, Issue:9

    Topics: Acenocoumarol; Bone and Bones; Developmental Disabilities; Drug Combinations; Female; Fetal Diseases; Gestational Age; Humans; Hydrochlorothiazide; Infant, Newborn; Labetalol; Lupus Erythematosus, Systemic; Prednisolone; Pregnancy; Pregnancy Complications; Prognosis; Risk Factors

1993
Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Oct-01, Volume: 53, Issue:19

    Topics: Antihypertensive Agents; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Diuretics; Dosage Forms; Drug Compounding; Drug Stability; Humans; Hydrochlorothiazide; Labetalol; Metoprolol; Sodium Chloride Symporter Inhibitors; Spironolactone; Suspensions; Verapamil

1996
Hepatocellular necrosis associated with labetalol.
    Journal of clinical hypertension (Greenwich, Conn.), 2007, Volume: 9, Issue:4

    Topics: Antihypertensive Agents; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Female; Humans; Hydrochlorothiazide; Hypertension; Labetalol; Middle Aged; Necrosis

2007
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:12

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System

2010
Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020, Jun-01, Volume: 1146

    Topics: Adsorption; Antihypertensive Agents; Chromatography, High Pressure Liquid; Diltiazem; Furosemide; Humans; Hydrochlorothiazide; Irbesartan; Iron; Labetalol; Limit of Detection; Losartan; Metal Nanoparticles; Methyldopa; Nanocomposites; Polyvinyl Alcohol; Prazosin; Propranolol; Reproducibility of Results; Solid Phase Microextraction; Spironolactone; Valsartan

2020